Keyword: Biotech


Indivior Buys US Biotech Opiant

17.11.2022 -

British drugmaker Indivior has agreed to buy Opiant, a US biotech specializing in treatments for addiction and drug overdose. Indivior will pay about $145 million upfront...


Bavarian Nordic Struggles to Supply Monkeypox Shot

25.08.2022 -

To meet surging global demand for its Jynneos-branded monkeypox vaccine, Danish biotech Bavarian Nordic (BN) is pulling out all stops. Strategies include outsourcing...


Lonza and Israel Biotech Fund Collaborate

30.05.2022 -

Lonza and Israel Biotech Fund (IBF) have signed a framework agreement, under which the Swiss CDMO will provide advice and support for Israeli biotech companies. IBF is...

Markets & Companies

After the Big Covid-19 Storm

19.04.2022 -

What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...


Italian Biotech: A Vital and Dynamic Industry

19.11.2020 -

The biotech industry in Italy is vital and is showing a constant growth, report by Assobiotec and ENEA documents.

Strategy & Management

Outsourcing Services: from Gene to Patient

19.02.2020 -

Rentschler Biopharma SE, headquartered in Laupheim, Germany, is a leading, family-owned, full-service biopharma CDMO. Owing to agile decision making and efficient...

Strategy & Management

Innovative Chemistry Between Mountains and Lakes

09.12.2019 -

Swiss chemical, pharmaceutical and life sciences companies help drive research around the world, and major players have research activities in the US, Singapore, Japan...

Strategy & Management

Made in Switzerland – Exported Worldwide

06.12.2019 - The chemical, pharmaceutical and life sciences industries in Switzer­land — organized in the Scienceindustries trade association — account for 45% of total exports with around 70...